Draft Patents (Amendment), Rules, 2023
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
Patents
-
Big pharma at war with copycats
Why don't you sell it for Rs.5? Rs.1.2 lakh per month is too high." On September 11, Supreme Court Justices Aftab Alam and Ranjana Desai posed that question to Swiss drugmaker Novartis AG, fighting to
-
Ten years of the Biological Diversity Act
As India plays host to the Convention on Biological Diversity's 11th Conference of the Parties in Hyderabad in October 2012, this article takes a closer look at the country's legislation on the subject
-
Open source drug discovery in practice: A case study
Open source drug discovery offers potential for developing new and inexpensive drugs to combat diseases that disproportionally affect the poor. The concept borrows two principle aspects from open source
-
Drugs cleared without clinical trials
14 New Drug Molecules Approved Between Jan & July 2012, Only 9 Tested: Azad New Delhi: Drugs continue to be approved in India without having undergone proper clinical trials on the local population.
-
Drug patents: Showdown for pharma companies in Supreme Court
Novartis patent case up for hearing this week; judgment to have far-reaching impact Mumbai/London: The Supreme Court will hear final arguments starting this week in a landmark case over drug patents that
-
Generic HIV drugs will widen US treatment net
Upcoming patent expiries stand to make medicines cheaper — although less convenient.
-
Panel Proposes Linking Patented Drug Prices to Per Capita Income
An inter-ministerial group tasked with regulating prices of patented medicines has recommended using a per capita income-linked reference pricing mechanism, a proposal that may reduce prices of several
-
Prized or priced?: protection of India’s traditional knowledge related to biological resources and intellectual property
The traditional knowledge (TK) of India’s people touches many lives within the country and outside it. For the holders of TK, it is their very lives and thus valuable as is. For others who don’t live by
-
Bring order to unregulated health markets
Uncontrolled medical treatment in Asia and Africa costs lives and money. David Peters and Gerald Bloom call for governments, firms and citizen groups to get involved.
-
NIIST offers ‘clear’ banana fibre extraction knowhow
The National Institute for Inter-disciplinary Science and Technology (NIIST) is offering a technology for clear extraction of banana fibre on a non-exclusive basis. NIIST is an affiliate of the Council